Preventive therapy of experimental colitis with selected iron chelators and anti-oxidants

International Journal of Preventive Medicine

Volumn 3, Issue 4, 2012, Pages

  Minaiyan, Mohsen ^a   Mostaghel, Elahe ^b   Mahzouni, Parvin ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Novel Drug Delivery Systems Research Centre   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti oxidant; Inflammatory bowel disease; Iron chelator; Kojic acid; Maltol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; DEFERIPRONE; DEFEROXAMINE; IRON CHELATING AGENT; KOJIC ACID; MALTOL; PREDNISOLONE; SODIUM CHLORIDE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON LENGHT; COLON WEIGHT; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE MODEL; DRUG MEGADOSE; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NONHUMAN; PROPHYLAXIS; RAT; TOTAL COLITIS INDEX; TREATMENT DURATION; ULCER INDEX;

EID: 84865257014     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. th ed. New York: McGraw-Hill companies; 2006. p. 1009-11.
2. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078-86.
3. th ed. New York: McGraw Hill Companies; 2007. p. 1029-35.
4. Cross RK, Lapshin O, Finkelstein J. Patient subjective assessment of drug side effect in inflammatory bowel disease. J Clin Gastroenterol 2008;42:244-51.
5. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002;47:1266-78.
6. Loguercio C, D'Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, et al. Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Dig Dis Sci 1996;41:1204-11.
7. Hewitt SD, Hider RC, Sarpony P, Moriss CJ, Black DR. Investigation of the anti-inflammatory properties of hydroxypyridinones. Ann Rheum Dis 1989;48:382-8.
8. Anwar-Mohamed A, El-Kadi AO. Induction of cytochrome P450 1a1 by the food flavoring agent, maltol. Toxicol In Vitro 2007;21:685-90.
9. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC. Final report of the safety assessment of Kojic acid as used in cosmetics. Int J Toxicol 2010;29(6 Suppl):244S-73.
10. Kang KS, Yamabe N, Kim HY, Yokozawa T. Role of maltol in advanced glycation end products and free radicals: In-vitro and in-vivo studies. J Pharm Pharmacol 2008;60:445-52.
11. Kang KS, Kim HY, Pyo JS, Yokozawa T. Increase in the free radical scavenging activity of ginseng by heat processing. Biol Pharm Bull 2006;29:750-4.
12. Brtko J, Rondahl L, Fickova M, Hudecova D, Eybl V, Uher M. Kojic acid and its derivatives: History and present state of ART. Cent Eur J Public Health 2004;12(Suppl):S16-8.
13. Niwa Y, Akamatsu H. Kojic acid scavenges free radicals while potentiating leukocyte functions including free radical generation. Inflammation 1991;15:303-15.
14. Yoo DS, Lee J, Choi SS, Rho HS, Cho DH, Shin WC, et al. A modulatory effect of novel kojic acid derivatives on cancer cell proliferation and macrophage activation. Pharmazie 2010;65:261-6.
15. Minaiyan M, Ghannadi AR, Afsharipour M, Mahzouni P. Effect of hydroalcoholic and essential oil of Rosmarinus officinalis L. on TNBSinduced colitis in rats. Res Pharm Sci 2011;6 [In press]
16. Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, et al. Development of novel budesonide pellets based on CODESTM technology: In vitro/in vivo evaluation in induced colitis in rats. DARU 2011;19:107-17.
17. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. J Gastroenterol 1989;96:795-803.
18. Minaiyan M, Ghassemi-Dehkordi, Mahzouni P, Ansari-Roknabadi M. Effect of Matricaria aurea (Loefl.) Shultz-Bip. hydroalcoholic extract on acetic acid-induced acute colitis in rats. Iran J Basic Med Sci 2011;14:67-74.
19. Minaiyan M, Ghannadi AR, Nabi-Meibodi M, Mahzouni P. Antiulcerogenic effect of ginger (rhizome of Zingiber officinale Roscoe) hydroalcoholic extract on acetic acid-induced acute colitis in rats. Res Pharm Sci 2008;3:15-22.
20. Cooper H, Murthy S, Shah R, Sedergran D. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
21. Dieleman L, Palmen M, Akol H, Bloemena E, Pena A, Meuwissen S. Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immuno 1998;114:385-91.
22. Torres MI, Garcia-Martin M, Fernandez MI, Nietro N, Gil A, Rios A. Experimental colitis induced by trinitrobenzene sulfonic acid: an ultrastructural and histochemical study. Dig Dis Sci 1999;44:2523-9.
23. Poli E, Lazzaretti M, Grandi D, Pozzoli C, Coruzzi G. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. Neurochem Res 2001;26:1085-93.
24. Barrand MA, Callingham BA, Hider RC. Effect of the pyrones, maltol and ethyl maltol on iron absorption from the rat small intestine. J Pharm Pharmacol 1987;39:203-11.
25. Ballester I, Daddaoua A, Lopez-Posadas R, Nieto A, Suarez MD, Zarzuelo A, et al. The bisphosphonate alendronate improves the damage associated with trinitrobenzen sulfonic acid-induced colitis in rats. Br J Pharmacol 2007;151:206-15.
26. Carrier J, Aghdassi E, Cullen J, Allard JP. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 2002;132:3146-50.
27. Yamada Y, Marshall S, Specian RD, Grisham MB. A comparative analysis of two models of colitis in rats. Gastroenterology 1992;102:1524-34.
28. Emara AM, El Kelany RS, Moustafa KA. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats. Hum Exp Toxicol 2006;25:375-85.
29. Ablin J, Shalev O, Okon E, Karmeli F, Rachmilewitz D. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis 1999;5:253-61.
30. Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, et al. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: Cardiac iron and function comparison determined by quantitative magnetic resonance imaging. Haematologica 2011;96:41-7.
31. Taylor PD, Morrison IEG, Hider RC. Microcomputer application of nonlinear regression analysis to metal-ligand equilibria. Talanta 1998;35:507-12.
32. Dobbin PC, Hider RC. Iron chelation therapy. Chem Br 1990;6:565-8.